Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Aug 14.
Published in final edited form as: Clin Dysmorphol. 2012 Oct;21(4):183–190. doi: 10.1097/MCD.0b013e3283551fd0

Holoprosencephaly–polydactyly/pseudotrisomy 13: a presentation of two new cases and a review of the literature

Sophia M Bous a,c, Benjamin D Solomon a, Luitgard Graul-Neumann d, Heidemarie Neitzel d, Emily E Hardisty b, Maximilian Muenke a
PMCID: PMC4131985  NIHMSID: NIHMS611172  PMID: 22643382

Abstract

Patients with a combination of holoprosencephaly and polydactyly, but with apparently normal chromosomes, may be clinically diagnosed with holoprosencephaly–polydactyly syndrome (HPS), also termed pseudotrisomy 13. However, the criteria for HPS have been controversial since the advent of the diagnostic term, and a clear understanding of the condition lacks definitive delineation. We review the historical and current perspectives on the condition and analyze findings in 40 patients with apparent HPS, including cases from the literature and two previously unreported patients. Overall, our analysis suggests previously unrecognized trends in patients diagnosed with HPS. Specifically, there appears to be a higher prevalence of visceral anomalies, most significantly cardiac and genitourinary, but also with increased gastrointestinal, pulmonary, adrenal, skeletal, and renal abnormalities, in patients with HPS. Although these visceral anomalies may not be essential for the identification of HPS, clinicians should be aware of the presence of such characteristics in these patients to optimize management and help establish etiologies.

Keywords: holoprosencephaly, holoprosencephaly and polydactyly, polydactyly, pseudotrisomy, pseudotrisomy 13

Introduction

Holoprosencephaly (HPE) is the most common malformation of the human forebrain, occurring in one in 250 gestations, although only approximately one in 10 000 live-born infants present with the condition because of the high proportion of intrauterine lethality (Orioli and Castilla, 2010). In addition to characteristic structural brain abnormalities, patients typically have accompanying midline facial anomalies, which range from cyclopia or synophthalmia at the most severe end of the spectrum to findings such as hypotelorism and a single central maxillary incisor in less severely affected patients. The causes of HPE are highly heterogeneous. HPE may occur as one component in a syndrome, may be because of cytogenetic anomalies, or may occur because of mutations in over 10 identified genes associated with nonchromosomal, nonsyndromic HPE (Pineda-Alvarez et al., 2010; Solomon et al., 2010).

HPE is classified into four major types, depending on the degree of severity of brain malformations: alobar (the most severe type), semilobar, lobar, and the more recently described middle interhemispheric variant-type HPE (Hahn and Barnes, 2010). Patients may also have ‘microform’ HPE, in which conventional neuroimaging shows no brain anomalies consistent with frank HPE, but patients may have subtle facial features consistent with a midline deficit. Many patients with microform HPE are identified because of the birth of a severely affected relative (Solomon et al., 2010).

Although the causes of some types of syndromic HPE have been elucidated, others remain less well delineated. Holoprosencephaly–polydactyly syndrome (HPS) is one of the less understood entities, although several lines of enquiry provide interesting hints. Classically diagnosed in patients with a combination of HPE, polydactyly, and apparently normal chromosomes, the criteria for HPS, also called pseudotrisomy 13, have been controversial since the use of the term began (Cohen, 1989a, 1989b, 1989c; Hewitt et al., 1989). Here, we analyze findings in 40 patients with apparent HPS and review the historical and current perspectives on the condition. Our analysis shows key trends in HPS. First, normal chromosomes as a required criterion may not be justified, as cytogenetic abnormalities have been discovered in some patients, pointing to possible genetic causes. Second, along these lines, cytogenetic analysis, including newer microarray and large-scale sequencing techniques, may allow increased molecular understanding of the cause of HPS. Third, clinicians should be aware that patients may have other anomalies (e.g. cardiac and genitourinary), which are highly associated with HPS and should be evaluated for when encountering a patient with HPS.

Diagnostic controversies

There have been difficulties both in defining HPS and in clearly showing its existence as a unified phenotype. The similarity to hydrolethalus syndrome led to the proposal that they are manifestations of the same disorder (Bachman et al., 1990). Others disagreed, arguing that HPS is a separate entity (Cohen and Gorlin, 1992). Further delineation of the syndrome led to the suggestion that pseudotrisomy 13 can manifest without polydactyly, an anomaly previously believed essential to the diagnosis (Ramos-Arroyo et al., 1994). In an attempt to resolve the debate, new criteria were established, taking into account sporadic and familial types of HPS. According to this formulation, a sporadic occurrence would fulfill the diagnostic criteria in the case of a normal karyotype and one of the following: HPE and postaxial polydactyly; HPE and other abnormalities not including polydactyly; or postaxial polydactyly, brain abnormalities such as microcephaly, agenesis of corpus callosum, and/or hydrocephalus, as well as other abnormalities. Patients with familial HPS/pseudotrisomy 13 would require an affected sibling to have a normal karyotype and the same clinical criteria outlined for sporadic cases would apply (Lurie and Wulfsberg, 1993).

The controversy grew with the discovery that a normal karyotype, the third classic diagnostic criterion, may not always be evident in patients with HPS. Of the 40 cases described in Table 1, only 82% have seemingly normal karyotypes. Further, there may be underappreciated cytogenetic anomalies not apparent on conventional chromosome analysis that may account for the presence of HPS (Hewitt et al., 1989; Brown et al., 1993; Chen et al., 1998, 2005; Chang, 2003; Koolen et al., 2006; Bendavid et al., 2010; Marquis-Nicholson et al., 2011). As an aggregate, these developments are not surprising, given the growing availability and use of high-density microarrays. Microalterations on chromosome 13 may be the cause of HPS in some. Evidence suggests that the region in question lies in chromosome arm 13q, which includes the locus for ZIC2, a gene frequently mutated in HPE (Hewitt et al., 1989; Brown et al., 1993; Koolen et al., 2006). Other cytogenetic anomalies in patients with pseudotrisomy 13 include the partial deletion of chromosome 8p and duplication of 5q35.1 (Chen et al., 1998, 2005; Chang, 2003; Koolen et al., 2006). Another study described multiple (21) long contiguous stretches of homozygosity in a patient showing the features of pseudotrisomy 13 (Marquis-Nicholson et al., 2011).

Table 1.

Cases of holoprosencephaly–polydactyly syndrome/pseudotrisomy 13

Patient Craniofacial features Neuroanatomical description Limb features Genetic testinga Other abnormal features Specifics of other abnormal
features
References
1 Microphthalmia, facial cleft Hydrocephalus, HPE, ACC Peripheral hypoplasia of left
 arm, tetramelic octodactyly
NS Cardiac Consanguinity, cardiac defects Grote et al. (1984)
2 Maxillary agenesis, cleft
 palate
Alobar HPE, hydrocephalus Bilateral upper limb postaxial
 polydactyly, club foot
46,XY Cardiac, genitourinary ASD, VSD, cardiac valve
 abnormalities, microphallus,
 cryptorchidism
Young and Madders (1987)
3 Hypotelorism, malformed
 ears
Hydrocephalus Bilateral 2–3 toe syndactyly,
 right hand postaxial
 polydactyly, club foot
46,XY Genitourinary Ambiguous genitalia, imperforate
 anus
Atkin (1988)
4 Cyclopia, proboscis Alobar HPE Left foot postaxial polydactyly 46,XY Genitourinary Ambiguous genitalia Atkin (1988)
5 Anophthalmia Alobar HPE, hydrocephalus, occipital
 encephalocele, hypoplastic
 cerebellum and vermis
Postaxial polydactyly of the
 hands
46,XY Pulmonary Consanguinity, bilobed lungs Donnai (1988)
6 Hypotelorism, suborbital
 proboscis
Alobar HPE, hydrocephalus,
 hypoplasia of the pituitary/thyroid
 glands
Bilateral upper limb postaxial
 polydactyly
46,XX Renal Renal dysplasia, hirtsutism Moerman and Fryns (1988)
7 NS HPE Bilateral postaxial hexadactyly NS Other Affected sibling Moerman and Fryns (1988)
8 Proboscis, hypotelorism Alobar HPE Postaxial polydactyly NS Cardiac, genitourinary Ambiguous genitalia, two vessel
 cord, VSD, affected sibling
Moerman and Fryns (1988)
9 Cyclopia Alobar HPE Bilateral postaxial polydactyly of
 upper and lower limbs
NS Cardiac VSD, two vessel cord Shiota and Tanimura (1988)
10 Hypotelorism, absent nose,
 cleft lip/palate
Hydrocephalus, semilobar HPE, absent
 olfactory/chiasm/pituitary glands
Postaxial polydactyly in all
 extremities
46,XY Cardiac, gastrointestinal,
 adrenal
Consanguinity, adrenal agenesis,
 splenomegaly, heart defects,
 affected sibling
Hewitt et al. (1989)
11 Microphthalmia, cleft lip,
 low-set ears
Alobar HPE, occipital encephalocele,
 hydrocephalus
Postaxial polydactyly of the
 hands
46,XX Pulmonary Lung abnormalities Meinecke (1989)
12 Hypotelorism,
 microphthalmia
Hydrocephalus, absent frontal bone,
 lobar HPE, dysplastic basal ganglia,
 absent olfactory gland, corpus
 callosum, hippocampus, cerebellum
Postaxial polydactyly in the left
 hand and foot
46,XY Gastrointestinal Consanguinity, omphalocele,
 affected sibling
Bachman et al. (1990)
13 Microphthalmia, maxillary
 agenesis
Agenesis of brain structures,
 hydrocephalus
Postaxial polydactyly of both the
 hands and the left foot
NS Other Consanguinity Bachman et al. (1990)
14 Microcephaly, large anterior
 fontanelle, low-set ears,
 hooked nose,
 microretrognathia,
 hypertelorism
Enlarged cisterna magna, fused lateral
 ventricles suggestive of semilobar
 HPE
Hypoplasia of the first phalanx,
 left club foot, right hip
 dislocation
46,XX; patient’s father
 was mosaic 46XY/
 46XY (2;13)
 (2q24;13q33)
Cardiac, skeletal Suggestive of consanguinity, 13
 pairs of ribs, VSD, single palmar
 creases
Verloes et al. (1991)
15 Single nostril, median
 pseudocleft lip,
 hypotelorism,
 microphthalmia
Semilobar HPE, ACC, agenesis of
 septum pellucidum and falx cerebri
Postaxial polydactyly of the
 hands and feet
46,XY Gastrointestinal,
 genitourinary
Hypogenitalism, microphallus,
 Hirschsprung’s disease,
 thermoregulatory instability,
 electrolyte and thyroid hormone
 abnormalities
Ramaekers et al. (1989)
16 Hypotelorism, microcephaly,
 hypoplastic nose, cleft
 palate
Dysplastic vermis and cerebellar foci,
 absent olfactory bulbs/tracts
Unilateral postaxial polydactyly
 (postminimus) of the left foot
NS Cardiac Consanguinity, IUGR, single palmer
 creases, VSD, ASD, affected
 sibling
Hennekam et al. (1991)
17 Microcephaly, hypotelorism,
 microphthalmia, flat
 rudimentary nose,
 bilateral cleft lip/palate,
 low-set ears
Midline continuity of corpus striatum
 and thalamus suggestive of
 semilobar HPE
Not present 46,XY Genitourinary Consanguinity, microphallus,
 cryptorchidism, affected sibling
Hennekam et al. (1991)
18 Microphthalmia, cleft lip Seizures Postaxial hexadactyly of the
 hands
Normal karyotype, NS Other Consanguinity, apnea Cohen and Gorlin (1991)
19 Porboscus, cyclopia,
 microstomia, dysplastic
 ears
Hydramnios, holosphere Bilateral postaxial polydactyly of
 the upper limbs
46,XY Cardiac, adrenal ASD, hypoplastic adrenals Verloes et al. (1991)
20 Cleft palate, premaxillary
 agenesis
NS Bilateral postaxial polydactyly of
 the upper limbs
46,XX Cardiac, gastrointestinal Cardiomegaly, TOGV, malrotated
 gut
Verloes et al. (1991)
21 Labiopalatine cleft Hydrocephalus, macroopthalmia,
 semilobar HPE, aplasia of olfactory
 gland
Bilateral postaxial polydactyly of
 the upper limbs
46,XY Cardiac, gastrointestinal,
 genitourinary,
 pulmonary, skeletal
Penile hypoplasia, aplasia of heart,
 lungs, gallbladder, testes,
 vertebral anomalies
Verloes et al. (1991)
22 NS Hydrocephalus, alobar HPE, abnormal
 gyration
Bilateral postaxial polydactyly of
 the upper and lower limbs
46,XY Other Consanguinity Verloes et al. (1991)
23 Absent ocular globes, single
 nostril
NS Bilateral postaxial polydactyly 46,XY Cardiac, genitourinary,
 adrenal
Ambiguous genitalia, VSD,
 hypoplastic adrenal glands
Verloes et al. (1991)
24 Cleft lip, hypotelerism, flat
 nose, absence of
 premaxilla, low-set ears,
 micrognathia
Semilobar HPE Right hand postaxial
 polydactyly, upper limb
 shortness, radial hypoplasia,
 bilateral partial 2–3
 syndactyly of the toes
46,XX Cardiac, genitourinary AV canal defect, lung abnormalities,
 bicornuate uterus
Boles et al. (1992)
25 Micro/anophthalmia HPE Postaxial polydactyly Normal karyotype, NS Cardiac, renal Heart defects, renal hypoplasia,
 ambiguous genitalia
Higgins and Minnick (1992)
26 Cleft lip/palate HPE Postaxial polydactyly Normal karyotype, NS Cardiac, renal Heart defects, renal hypoplasia Higgins and Minnick (1992)
27 Cleft lip/palate,
 hypotelorism, absent
 nose
Semilobar HPE, absent olfactory lobes
 and optic nerves
Not present 46,XY; mother mosaic
 45,X/46,XX/47,XXX/
 48,XXXX
Other Sibling with poly/hexadactyly Seller et al. (1993)
28 Microcephaly, upslanted
 fissure, exophthalmos,
 hypotelorism, cleft
 lip/palate, abnormal ears
Alobar HPE, seizures Not present 46,XX Cardiac, genitourinary Heart anomalies, uterine duplication Ramos-Arroyo et al. (1994)
29 Microcephalic,
 microphthalmia,
 hypotelorism,
 cebocephalus,
 pseudocleft palate
Alobar HPE, absent olfactory and optic
 nerves, dysgenesis of hypopituitary,
NS 46,XX Gastrointestinal, pulmonary,
 adrenal
Acrocyanosis, choanal atresia, lung
 and spleen abnormalities,
 dysgenesis of thyroid and adrenal
 glands
Koolen et al. (2006)
30 Hypotelorism, pseudocleft
 palate
Alobar HPE with fused thalamus,
 absent olfactory and optic nerves,
 dysgenesis of hypopituitary
Preaxial polydactyly of the left
 hand
46,XX Gastrointestinal, adrenal Choanal atresia, dysgenesis of
 thyroid and adrenal glands
Koolen et al. (2006)
31 Hypotelorism, nasal
 hypoplasia, midface cleft,
 premaxillary agenesis,
 low-set ears
Alobar HPE, absent olfactory and optic
 nerves
Postaxial polydactyly of the right
 hand
46,XX, partial trisomy
 13q (13q22→qter)
 and partial
 monosomy 8p
 (8p23.3→pter)
Cardiac Hypoplastic left heart Chang (2003)
32 Macrocephaly,
 microagnathia, cleft
 lip/palate, hypertelorism,
 low-set ears, broad nose
Hydrocephalus, midline
 brain defect NS
Club foot 46,XY Cardiac Laryngeal stenosis, ASD Cakir et al. (2006)
33 Microcephaly, hypotelorism,
 flat rudimentary nose,
 single nasal opening, high
 palate, dysplastic low-set
 ears
Alobar HPE Postaxial polydactyly of the
 upper limbs
46,XX Cardiac, gastrointestinal,
 genitourinary
Single creases, ASD, ventricular
 hypoplasia, duodenal stenosis
Ahmet et al. (2006)
34 Facial dysmorphic features,
 NS
Lobar HPE, seizures Right preaxial polydactyly dup5q35.1 Cardiac, genitourinary Vesicoureteral reflux, VSD Chen et al. (2005)
35 Hypotelorism, cleft lip, flat
 nose, single nostril, low-set
 ears
Semilobar HPE, hydrocephalus Postaxial polydactyly in all
 extremities
46,XY Cardiac, pulmonary Consanguinity, lung abnormalities,
 VSD
Utine et al. (2008)
36 Macrocephalic, extropia,
 hypoplastic
 ala nasae
Semilobar HPE, hydrocephalus Polysyndactyly in all
 extremities
46,XY; negative for
 mutations in
  SHH, ZIC2, SIX3,
TGIF, GLI3,
  FBXWII, DISP1.
 Normal DHCR7
Other Hemangioma, hypotonia, motor
 delay
Cordero et al. (2008)
37 Cleft lip/palate Semilobar HPE Bilateral syndactyly and
 hypoplasia of the toes
46XY, negative for
 mutations in SHH,
TGIF, SIX3, GLI2,
  TIP73L, DHCR7
Genitourinary Ectopic testes, microphallus Zechi-Ceide et al. (2009)
38 Hypotelorism, cleft lip/
 palate, brachycephalic
 contour of the skull, flat
 nose with midline groove
 and shallow dimples in
 place of the nostrils, low-
 set ears
HPE, rudimentary falx and cerebral
 hemispheres replaced by a
 holosphere, interhemispheric fissure
Postaxial polydactyly, partial
 syndactyly
46,XX, with 21 noted
 LCSHs
Cardiac, pulmonary, adrenal VSD, incomplete lobation of the
 right lung with rudimentary
 horizontal and oblique fissures,
 adrenal hypoplasia, possible
 affected siblings
Marquis-Nicholson et al. (2011)
39 Cleft lip/palate, flat nose HPE Hexadactyly, thumb hypoplasia,
 right radial deviation
46,XY, no deletion of
 7q36 or
  22q11.2, no
 cholesterol
  abnormalities,
 negative SHH, ZIC2,
SIX3, TGIF
Cardiac, genitourinary,
 skeletal
Tetralogy of Fallot, hypospadias,
 vertebral anomalies, hypotonia
This report
40 Proboscis HPE Polydactyly, NS Normal karyotype,
 negative for
  mutations in SHH,
ZIC2, SIX3, TGIF,
GLI2, and normal
  oligonucleotide
 array CGH
  (Signature)
Cardiac,
 skeletal
Cardiac and vertebral anomalies This report

The amount of information was variable for patients, and details are given as specified in the original sources; hence, the terminology may differ slightly between patients so as not to alter data through misinterpretation. ACC, agenesis of the corpus callosum; ASD, atrial septal defect; AV, atrioventricular; HPE, holoprosencephaly; IUGR, intrauterine growth restriction; LCSHs, long contiguous stretches of homozygosity; NS, not specified; TOGV, transposition of the great vessels; VSD, ventricular septal defect.

a

By conventional chromosome analysis (karyotype) unless otherwise noted.

Theories of causation

The molecular pathogenesis of HPS is poorly understood and is likely complex. Traditionally, HPE is thought to be a result of a loss-of-function mutation, while polydactyly is thought to be a result of a gain-of-function mutation (Clark et al., 2001). One hypothesis for why both loss-of-function and gain-of-function effects may result from the same pleiotropic mutation is that the response to the signals from the gene(s) responsible for HPS may differ because of varying embryologic patterning of the brain and limbs. Alternatively, the phenotype may result from two or more mutations involving different genes or an as yet undiscovered contiguous gene syndrome, resulting in brain and limb anomalies (Cordero et al., 2008).

Sonic hedgehog (SHH) is a key molecule in the pathogenesis of HPE and many genes implicated in HPE are tied to the SHH signaling pathway (Solomon et al., 2010). The presence of HPE because of diverse causes such as Smith–Lemli–Opitz syndrome, maternal alcohol use, and the use of the cholesterol-lowering statin class of medications during pregnancy may all be tied to SHH signaling (Lanoue et al., 1997; Edison and Muenke, 2004; Li et al., 2007). Further, aberrant SHH signaling is also associated with disorders that manifest polydactyly, including Pallister–Hall syndrome, Greig cephalopolysyndactyly, and isolated postaxial polydactyly (Ming et al., 1998). Thus, it is highly plausible that hedgehog signaling may be involved in HPS despite the fact that mutations in the SHH gene itself have not yet been identified in patients with HPS.

Nonetheless, it is likely that HPS is a heterogeneous disorder, as shown by theories of HPS inheritance. Among the cases in Table 1, 28% describe parental consanguinity, leading to the suspicion of autosomal recessive inheritance in some cases (Ramaekers et al., 1989; Bachman et al., 1990; Brown et al., 1993; Ahmet et al., 2006; Marquis-Nicholson et al., 2011). Eighteen percent of cases were found to have an affected sibling with HPS. However, the possibility of an X-linked or an autosomal dominant mode of inheritance cannot be ruled out (Atkin, 1988; Seller et al., 1993). Although more males overall (45%) are reported than females (28%), both sexes are significantly represented. Finally, germline mosaicism is well described in isolated HPE, and must not be ignored when discussing possible inheritance patterns (Ramaekers et al., 1989; Solomon et al., 2010).

Differential diagnosis

With the broader inclusion criteria described above, some cases significantly overlap with other disorders, which may lead to difficulties in establishing a diagnosis. Conditions that share common characteristics with HPS include hydrolethalus syndrome and trisomy 13. Other conditions may have overlapping features, such as Smith–Lemli–Opitz syndrome, Meckel syndrome, and Pallister–Hall syndrome, necessitating a full clinical genetic consultation to help determine whether or not these other diagnoses should be pursued by targeted testing.

Genetic evaluation in a few recent cases of HPS ruled out some of these disorders in at least the tested individuals (Cordero et al., 2008; Zechi-Ceide et al., 2009). However, it must be stated that with many of the patients described in our analysis, it is difficult to exclude all overlapping conditions, as not all have had the same clinical diagnostic work-up or extensive molecular testing. In fact, it may well be that patients diagnosed with HPS represent a causally heterogeneous group of patients. As molecular understanding of diseases advances, the aggregate diagnosis of HPS may dissolve into separate conditions.

Materials and methods

We report on two patients who participated in our National Human Genome Research Institute Institutional Review Board approved protocol on HPE, with appropriate consent obtained from participating families. Samples and available clinical information were sent to our lab from referring clinicians, and sequencing of HPE-associated genes was performed through standard dideoxynucleotide sequencing (methods described in detail in Pineda-Alvarez et al., 2010).

We analyzed findings in 38 additional previously reported patients with apparent HPS using Pubmed and Medline as search mechanisms with the search terms including ‘holoprosencephaly’, ‘HPE’, ‘pseudotrisomy’, ‘pseudotrisomy 13’, and ‘holoprosencephaly and polydactyly’.

Results

New patient reports

Patient 39 was a 1-year-old male first child of nonconsanguineous parents of western European descent who had an unremarkable family history. Neuroimaging during gestation showed a partial fusion in the rostral basal ganglia believed to represent mild HPE, as well as a lipoma of the corpus callosum. Postnatal MRI confirmed these findings, and indicated that a single maxillary central incisor was not present. Birth measurements showed that head circumference, height, and weight were all below the third centile for gestational age; measurements at 12 months of age showed a weight between the 10th and the 25th centile, body length between the 50th and the 75th centile, and microcephaly, with occipito-frontal head circumference less than the third centile. Facial features were consistent with HPE, with marked midface hypoplasia, a flattened nasal bridge, and a midline cleft lip and palate. Limb anomalies included left upper extremity radial deviation and thumb hypoplasia and evidence of right upper extremity preaxial hexadactyly (status-post surgical correction at the time of examination). Additional anomalies included tetralogy of Fallot, multiple fused and hemivertebrae resulting in scoliosis, hypospadias, and micropenis. The patient showed generalized hypotonia and severe motor delay. Laboratory analysis indicated evidence of diabetes insipidus, but no other endocrinological abnormalities. Karyotype analysis, fluorescence in-situ hybridization for 7q36 and 22q11.2, as well as quantitative cholesterol levels were all normal. Sequence analysis of SHH, ZIC2, SIX3, and TGIF indicated no mutations. An oligonucleotide array CGH (Signature) was not performed.

Patient 40 was diagnosed in utero with HPS. Imaging indicated neuroanatomical anomalies consistent with severe HPE, as well as the presence of a proboscis, polydactyly, cardiac defects, and hemivertebrae. Full autopsy was not performed and further data are not available. Karyotype analysis and oligonucleotide array CGH (Signature) showed no abnormalities. Sequence analysis of SHH, ZIC2, SIX3, TGIF, and GLI2 indicated no mutations.

Combined findings

Patients diagnosed with HPS are presented in Table 1. The availability of clinical details was variable. Slightly less than 80% of patients were described as having classic HPE and 92% overall were found to have some type of central nervous system defect. Brain anomalies were not recorded in 8% of the patients; however, facial features in these cases were consistent with a diagnosis of HPE. These features include eye abnormalities, such as hypotelorism (70%), cleft lip and/or palate (53%), nose anomalies consistent with HPE (28%), and, separately, proboscis (10%). In patients in whom the HPE type was described, there was a skewing toward severe forms. Thirty-three percent of the patients had alobar, 25% had semilobar, and 5% had lobar HPE.

Polydactyly was described in 80% of patients, whereas 93% had some type of limb abnormality, including polydactyly. At least 95% of patients with polydactyly had postaxial polydactyly. Although organ system defects are not believed to be essential to the diagnosis of HPS, there was a high prevalence of cardiac (58%), genitourinary (35%), gastrointestinal (20%), pulmonary (15%), adrenal (10%), skeletal (10%), and renal (8%) abnormalities (for a more detailed description of the patients, please refer to Table 1).

Discussion

Although first described over two decades ago, the definitive diagnosis of HPS remains a challenge. First, the criteria of HPE, polydactyly, and normal chromosomal analysis have served as a guideline for the diagnosis of the syndrome. A broadened list of criteria was subsequently created (Lurie and Wulfsberg, 1993). Since these criteria were established, more extensive cytogenetic methodologies have become available, leading to the discovery of distinct anomalies found on several chromosomes that may be linked to causes of HPS. Our data suggest that normal chromosomes were found in most but not all cases of HPS. Further, sequencing results from the new patients reported here lend support to the hypothesis that mutations in known and well-characterized HPE-associated genes are not common causes of HPS. With the increased use of newer genomic diagnostic techniques such as high-density microarrays and high-throughput sequencing, smaller regions of genomic variance and individual exonic mutations may be better appreciated, and may possibly lead to an improved understanding of the complex etiology of the condition. It is entirely possible that HPS will remain a unifying clinical diagnosis that can result from many possible genetic and environmental causes, as has been well described for HPE in general (Solomon et al., 2010). When a clinician considers a diagnosis of HPS, genetic studies on both a clinical and a research basis should be pursued to further understand the condition, as well as to improve the management of these patients.

Second, our data highlight a high prevalence of a variety of visceral anomalies, most significantly involving the cardiac and genitourinary systems, in patients with HPS. This prevalence of visceral anomalies in HPS appears overall higher than in HPE more generally. In a recent and impressively large study describing a cohort of over 600 European patients with HPE, 27% were found to have visceral anomalies (Mercier et al., 2011). Although perhaps not essential for the identification of HPS, clinicians should be aware of the presence of such characteristics in these patients. These findings may also point to potential causes. For example, the neuroanatomical anomalies of HPE can naturally lead to a variety of endocrinologic disturbances, but adrenal cortical development appears to be directly linked to the SHH signaling pathway (Ching and Vilain, 2009; King et al., 2009; Huang et al., 2010), implying a role for this pathway in at least some patients.

Finally, along these lines, we suggest the following for work-up of a patient in whom a clinician is considering a diagnosis of HPS: detailed clinical exam by a geneticist to assess for polydactyly and other anomalies, with further studies as indicated; neuroimaging (MRI is preferred) to establish the presence and type of HPE as well as other central nervous system anomalies; echocardiogram; renal ultrasound; conventional karyotype, with reflex microarray if the karyotype is negative; further targeted genetic testing if other conditions in the differential diagnosis appear likely; as well as consideration of research participation.

Acknowledgements

The authors would like to thank all the patients who participated in these studies. This research was supported by the Division of Intramural Research, National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services, USA.

Footnotes

Conflicts of interest There are no conflicts of interest.

References

  1. Ahmet D, Bahri E, Mustafa A, Varim N, Tunc T. Pseudotrisomy 13 syndrome: a case with left ventricular hypoplasia and duodenal stenosis. Clin Dysmorphol. 2006;15:41–42. doi: 10.1097/01.mcd.0000184970.91904.fd. [DOI] [PubMed] [Google Scholar]
  2. Atkin JF. A new syndrome with cyclopia and trisomy 13 features. Am J Hum Genet. 1988;43:A36. [Google Scholar]
  3. Bachman H, Clark RD, Salahi W. Holoprosencephaly and polydactyly: a possible expression of the hydrolethalus syndrome. J Med Genet. 1990;27:50–52. doi: 10.1136/jmg.27.1.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bendavid C, Dupe V, Rochard L, Gicquel I, Dubourd C, David V. Holoprosencephaly: an update of cytogenetic abnormalities. Am J Hum Genet. 2010;154C:86–92. doi: 10.1002/ajmg.c.30250. [DOI] [PubMed] [Google Scholar]
  5. Boles RG, Teebi AS, Neilson KA, Meyn MS. Pseudo-trisomy 13 syndrome with upper limb shortness and radial hypoplasia. Am J Med Genet. 1992;44:638–640. doi: 10.1002/ajmg.1320440522. [DOI] [PubMed] [Google Scholar]
  6. Brown S, Gersen S, Anyane-Yeboa K, Warbuton D. Preliminary definition of a ‘critical region’ of chromosome 13 in q32: report of 14 cases with 13q deletion and review of the literature. Am J Med Genet. 1993;45:52–59. doi: 10.1002/ajmg.1320450115. [DOI] [PubMed] [Google Scholar]
  7. Cakir M, Mungan I, Makuloglu M, Okten A. Hydrocephalus with cleft lip and palate: an overlap between midline malformation syndromes. Indian J Pediatr. 2006;73:731–733. doi: 10.1007/BF02898455. [DOI] [PubMed] [Google Scholar]
  8. Chang L. Alobar holoprosencephaly: report of two cases with unusual findings. Chang Gung Med J. 2003;26:700–706. [PubMed] [Google Scholar]
  9. Chen C, Chern S, Lee C, Chen L, Chuang C, Chen M. Prenatal diagnosis of de novo isochromosome 13q associated with microcephaly, alobar holoprosencephaly and cebocephaly in a fetus. Prenat Diagn. 1998;18:393–398. [PubMed] [Google Scholar]
  10. Chen C, Chern S, Hsu C, Lee C, Lee M, Wang W. Prenatal diagnosis of de novo partial trisomy 13q (13q22→qter) and partial monosomy 8p (8p23.3→pter) associated with holoprosencephaly, premaxillary agenesis, hexadactyly, and a hypoplastic left heart. Prenat Diagn. 2005;25:331–337. doi: 10.1002/pd.1126. [DOI] [PubMed] [Google Scholar]
  11. Ching S, Vilain E. Targeted disruption of sonic hedgehog in the mouse adrenal leads to adrenocortical hypoplasia. Genesis. 2009;47:628–637. doi: 10.1002/dvg.20532. [DOI] [PubMed] [Google Scholar]
  12. Clark RM, Marker PC, Roessler E, Dutra A, Schimenti JC, Muenke M, Kingsley DM. Reciprocal mouse and human limb phenotypes caused by gain- and loss-of-function mutations affecting Lmbr1. Genetics. 2001;159:715–726. doi: 10.1093/genetics/159.2.715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cohen MM., Jr Perspectives on holoprosencephaly. Part I. Epidemiology, genetics, and syndromology of holoprosencephaly. Teratology. 1989a;40:211–235. doi: 10.1002/tera.1420400304. [DOI] [PubMed] [Google Scholar]
  14. Cohen MM., Jr Holoprosencephaly and cytogenetic finding: further information. Am J Med Genet. 1989b;34:265. doi: 10.1002/ajmg.1320340229. [DOI] [PubMed] [Google Scholar]
  15. Cohen MM., Jr Perspectives on holoprosencephaly. Part III. Spectra, distinctions, continuities, and discontinuities. Am J Med Genet. 1989c;34:271–288. doi: 10.1002/ajmg.1320340232. [DOI] [PubMed] [Google Scholar]
  16. Cohen MM, Jr, Gorlin RJ. Pseudo-trisomy 13 syndrome. Am J Med Genet. 1991;39:332–335. doi: 10.1002/ajmg.1320390316. [DOI] [PubMed] [Google Scholar]
  17. Cohen MM, Jr, Gorlin RJ. Problems in the delineation of pseudotrisomy syndrome: reply to Drs. Norman, Donnai, Martínez-Frías, Urioste, Martín, and Frías. Am J Med Genet. 1992;43:636–638. [Google Scholar]
  18. Cordero DR, Bendavid C, Shanske AL, Haddad BR, Muenke M. Holoprosencephaly-polydactyly syndrome: in search of an etiology. Eur J Med Genet. 2008;51:106–112. doi: 10.1016/j.ejmg.2007.08.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Donnai D. Unknown case: stillborn white male-30 weeks. Proc Gr Genet Center. 1988;7:64–65. [Google Scholar]
  20. Edison RJ, Muenke M. Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins. Am J Med Genet. 2004;131:287–298. doi: 10.1002/ajmg.a.30386. [DOI] [PubMed] [Google Scholar]
  21. Grote W, Rehder H, Weisner D, Wiedemann HR. Prenatal diagnosis of a probably hereditary syndrome with holoprosencephaly, hydrocephaly, octodactyly, and cardiac malformations. Eur J Pediatr. 1984;143:155–157. doi: 10.1007/BF00445808. [DOI] [PubMed] [Google Scholar]
  22. Hahn JS, Barnes PD. Neuroimaging advances in holoprosencephaly: refining the spectrum of the midline malformation. Am J Med Genet C Semin Med Genet. 2010;154C:120–132. doi: 10.1002/ajmg.c.30238. [DOI] [PubMed] [Google Scholar]
  23. Hennekam RC, Van Noort G, De La Fuente AA. Familial holoprosencephaly, heart defects, and polydactyly. Am J Med Genet. 1991;41:258–262. doi: 10.1002/ajmg.1320410226. [DOI] [PubMed] [Google Scholar]
  24. Hewitt BG, Seller MJ, Bennett CP, Maxwell DM. Holoprosencephaly, polydactyly and normal chromosomes: pseudo-trisomy 13? Clin Genet. 1989;36:141–143. doi: 10.1111/j.1399-0004.1989.tb03177.x. [DOI] [PubMed] [Google Scholar]
  25. Higgins JV, Minnick MA. Pseudo-trisomy 13 syndrome: prenatal findings in a family with two affected siblings. Am J Hum Genet. 1992;51:257. [Google Scholar]
  26. Huang CJ, Miyagawa S, Matsumaru D, Parker KL, Yao HH. Progenitor cell expansion and organ size of mouse adrenal is regulated by sonic hedgehog. Endocrinology. 2010;151:1119–11128. doi: 10.1210/en.2009-0814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. King P, Paul A, Lauger E. Shh signaling regulates adrenocortical development and identifies progenitors of steroidogenic lineages. PNAS. 2009;106:21185–21190. doi: 10.1073/pnas.0909471106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Koolen DA, Herbergs J, Veltman JA, Pfundt R, van Bokhoven H, Stroink H, et al. Holoprosencephaly and preaxial polydactyly associated with a 1.24 Mb duplication encompassing FBXW11 at 5q35.1. J Hum Genet. 2006;51:721–726. doi: 10.1007/s10038-006-0010-8. [DOI] [PubMed] [Google Scholar]
  29. Lanoue L, Dehart DB, Hinsdale ME, Maeda N, Tint GS, Sulik KK. Limb, genital, CNS, and facial malformations result from gene/environment-induced cholesterol deficiency: further evidence for a link to sonic hedgehog. Am J Med Genet. 1997;73:24–31. [PubMed] [Google Scholar]
  30. Li YX, Yang HT, Zdanowicz M, Sicklick JK, Qi Y, Camp TJ, Diehl AM. Fetal alcohol exposure impairs hedgehog cholesterol modification and signaling. Lab Invest. 2007;87:231–240. doi: 10.1038/labinvest.3700516. [DOI] [PubMed] [Google Scholar]
  31. Lurie IW, Wulfsberg EA. ‘Holoprosencephaly-polydactyly’ (pseudotrisomy 13) syndrome: expansion of the phenotypic spectrum. Am J Med Genet. 1993;47:405–409. doi: 10.1002/ajmg.1320470322. [DOI] [PubMed] [Google Scholar]
  32. Marquis-Nicholson R, Aftimos S, Ashton F, Love JM, Stone P, McFarlane J, et al. Pseudotrisomy 13 syndrome: use of homozygosity mapping to target candidate genes. Gene. 2011;486:37–40. doi: 10.1016/j.gene.2011.06.028. [DOI] [PubMed] [Google Scholar]
  33. Meinecke P. Letter to the editor: holoprosencephaly, polydactyly and a lethal outcome-another observation. Proc Gr Genet Center. 1989;8:78–79. [Google Scholar]
  34. Mercier S, Dubourg C, Garcelon N, Campillo-Gimenez B, Gicquel I, Belleguic M, et al. New findings for phenotype-genotype correlations in a large European series of holoprosencephaly cases. J Med Genet. 2011;48:752–760. doi: 10.1136/jmedgenet-2011-100339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Ming JE, Roessler E, Muenke M. Human developmental disorders and the sonic hedgehog pathway. Mol Med Today. 1998;4:343–349. doi: 10.1016/s1357-4310(98)01299-4. [DOI] [PubMed] [Google Scholar]
  36. Moerman P, Fryns JP. Holoprosencephaly and postaxial polydactyly: another observation. J Med Genet. 1988;25:501–504. doi: 10.1136/jmg.25.7.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Orioli IM, Castilla EE. Epidemiology of holoprosencephaly: prevalence and risk factors. Am J Med Genet C Semin Med Genet. 2010;154C:13–21. doi: 10.1002/ajmg.c.30233. [DOI] [PubMed] [Google Scholar]
  38. Pineda-Alvarez DE, Dubourg C, David V, Roessler E, Muenke M. Current recommendations for the molecular evaluation of newly diagnosed holoprosencephaly patients. Am J Med Genet C Semin Med Genet. 2010;154C:93–101. doi: 10.1002/ajmg.c.30253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Ramaekers PR, Legius E, Verloes A, Gillerot Y, Vandenberghe K, Fryns JP. Holoprosencephaly and postaxial polydactyly with normal chromosomes. Another observation of a new malformation syndrome; a case report. Eur J Obstet Gynecol Reprod Biol. 1989;36:161–165. doi: 10.1016/0028-2243(90)90062-6. [DOI] [PubMed] [Google Scholar]
  40. Ramos-Arroyo MA, de Miguel C, Valiente A, Moreno-Languna S. Further delineation of pseudotrisomy 13 syndrome: a case without polydactyly. Am J Med Genet. 1994;50:177–179. doi: 10.1002/ajmg.1320500208. [DOI] [PubMed] [Google Scholar]
  41. Seller MJ, Chitty LS, Dunbar H. Pseudotrisomy 13 and autosomal recessive holoprocencephaly. J Med Genet. 1993;30:970–971. doi: 10.1136/jmg.30.11.970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Shiota K, Tanimura T. Letter to the editor: holoprosencephaly, ventricular septal defect and postaxial polydactyly in a human embryo. J Med Genet. 1988;25:502–503. doi: 10.1136/jmg.25.7.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Solomon BD, Mercier S, Vélez JI, Pineda-Alvarez DE, Wyllie A, Zhou N, et al. Analysis of genotype-phenotyp correlations in human holoprosencephaly. Am J Med Genet C Semin Med Genet. 2010;154C:133–141. doi: 10.1002/ajmg.c.30240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Utine GE, Alanay Y, Aktas D, Talim B, Kale G, Tuncbilek E. Pseudo-trisomy 13 in a fetus: further support for autosomal recessive inheritance. Turk J Pediatr. 2008;50:287–290. [PubMed] [Google Scholar]
  45. Verloes A, Ayme S, Gambarelli D, Gonzales M, Le Merrer M, Mulliez N, et al. Holoprosencephaly-polydactyly (‘pseudotrisomy 13’) syndrome: a syndrome with features of hydrolethalus and Smith–Lemli–Opitz syndrome: a collaborative multicenter study. J Med Genet. 1991;28:297–303. doi: 10.1136/jmg.28.5.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Young ID, Madders DJ. Unknown syndrome: holoprosencephaly, congenital heart defects, and polydactyly. J Med Genet. 1987;24:714–716. doi: 10.1136/jmg.24.11.714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Zechi-Ceide RM, Ribeiro LA, Raskin S, Pereira Bertolacini CD, Guion-Almeida ML, Richieri-Costa A. Holoprosencephaly, ectrodactyly, and bilateral cleft of lip and palate: exclusion of SHH, TGIF, SIX3, GLI2, TP73L, and DHCR7 as candidate genes. Am J Med Genet. 2009;149A:1277–1279. doi: 10.1002/ajmg.a.32844. [DOI] [PubMed] [Google Scholar]

RESOURCES